Dr. Reddy’s, Wipro, HDFC Life and other top stocks to watch out for on September 8

Sep 8, 2021

By: Rounak Jain

Dr. Reddy's Laboratories

Completed the sale of its oncology immunotherapy drug licence to Citius.

Credit: Dr-Reddys-Laboratories

Contd...

Initiated the supply of the first dose of the Sputnik V vaccine to its partner hospitals across the country.

Credit: Dr-Reddys-Laboratories

Wipro

Partnered with Securonix to deliver cyber security services to its clients.

Credit: Wipro

HDFC Life Insurance

Convened an extraordinary general meeting (EGM) on September 29 to seek their approval for issuance of preference shares to complete the ₹6,687 crore acquisition of Exide Life.

Credit: HDFC-Life-Insurance

Earnings today

Windlas Biotech.

Credit: Pixabay

IPO Watch

Ami Organics and Vijaya Diagnostic IPO allotments are likely to be announced today.

Credit: Flickr

TVS Motor

Appointed ETG Logistics as its distributor in South Africa, to open and operate 30 dealerships in the country as part of the partnership.

Credit: BCCL

Cipla

Has requested the National Pharmaceutical Pricing Authority to allow it to increase the prices of the certain respiratory drugs, citing an increase in input costs.

Credit: Cipla

ICRA

LIC offloaded over 2 lakh equity shares in the open market, bringing down its holding to 5.81 percent from 7.96 percent.

Credit: ICRA

PSP Projects

Has received Letter of Intents for projects worth ₹133 crore in Gujarat.

Credit: PSP-Projects

Adani family infuses ₹6,661 crore in Ambuja Cements, increases stake to 66.7%